NCT04210011 is a clinical trial in Parents of Children With Cancer, sponsored by The University of Hong Kong.

Who is sponsoring NCT04210011?

NCT04210011 is sponsored by The University of Hong Kong.

What condition does NCT04210011 study?

NCT04210011 studies Parents of Children With Cancer.

Is NCT04210011 still recruiting?

NCT04210011 is currently status unknown. Last updated 25 March 2020.

Last reviewed 2020-03-25 · How we verify

NCT04210011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhancing the Resilience of Parents by Understanding Their Perceptions, Behaviour, Attitudes, and Experiences Related to Cancer and Its Treatment of Their Child

Status unknown Last updated 25 March 2020

What this trial tests

trial in Parents of Children With Cancer in 114 participants. Status unknown.

Timeline

2 January 2020

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	The University of Hong Kong
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	114
Start date	2 January 2020
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across Hong Kong

Conditions studied

Parents of Children With Cancer — all drugs for Parents of Children With Cancer →

Sponsor

The University of Hong Kong

Who can join

Eligibility, any sex, with Parents of Children With Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to describe the psychosocial well-being and quality of life of Hong Kong Chinese parents of children with cancer with the aim at understanding the needs and concerns of parents, including their perceptions, behaviour, attitudes, and experiences related to cancer and its treatment of their child.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parents of Children With Cancer

Currently open trials in the same condition.

NCT06651242 — Decision Support Intervention of Minor Cancer Patients and Their Parents · NA · recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04210011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 25 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04210011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing